These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Beneficial effects of integrin αvβ3-blocking RGD peptides in early but not late phase of experimental glomerulonephritis. Amann K; Haas CS; Schüssler J; Daniel C; Hartner A; Schöcklmann HO Nephrol Dial Transplant; 2012 May; 27(5):1755-68. PubMed ID: 22049183 [TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats. Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273 [TBL] [Abstract][Full Text] [Related]
24. [Vaccination of mice with recombinant nucleic acid vaccine encoding the integral membrane protein Sj23 and cytokine IL-12 elicits specific immune responses against schistosoma japonica]. Gan Y; Shi YE; Bu LY; Ning CX; Zhu HG Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):193-8. PubMed ID: 15854467 [TBL] [Abstract][Full Text] [Related]
25. [Interleukin-12 gene transfection into murine B16 melanoma cells suppresses tumorigenicity and decreases metastatic potential]. Fu J; Zheng J; Fang W Zhonghua Yi Xue Za Zhi; 1998 Aug; 78(8):627-9. PubMed ID: 11038817 [TBL] [Abstract][Full Text] [Related]
26. Fas-Fas ligand signaling pathway mediates an interleukin-12-induced rejection of a murine prostate tumor system. Zhang S; Zeng G; Kao C; Gardner T; Sweeney C; Yang NS; Eble JN; Cheng L Prostate; 2002 Sep; 53(1):69-76. PubMed ID: 12210482 [TBL] [Abstract][Full Text] [Related]
27. Production and degradation of extracellular matrix in reversible glomerular lesions in rat model of habu snake venom-induced glomerulonephritis. Kawazu T; Nishino T; Obata Y; Furusu A; Miyazaki M; Abe K; Koji T; Kohno S Med Mol Morphol; 2012 Dec; 45(4):190-8. PubMed ID: 23224597 [TBL] [Abstract][Full Text] [Related]
28. Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer. Li S; Zhang L; Torrero M; Cannon M; Barret R Mol Ther; 2005 Nov; 12(5):942-9. PubMed ID: 15953768 [TBL] [Abstract][Full Text] [Related]
29. Analysis of glomerular VEGF mRNA and protein expression in murine mesangioproliferative glomerulonephritis. Haas CS; Câmpean V; Kuhlmann A; Dimmler A; Reulbach U; Forster C; Aigner T; Acker T; Plate K; Amann K Virchows Arch; 2007 Jan; 450(1):81-92. PubMed ID: 17120027 [TBL] [Abstract][Full Text] [Related]
30. [The action of cyclophosphane in different morphological variants of glomerulonephritis in mice]. Samoĭlov DV; Ivanov AA; Gladskikh OP; Krasnova TN; Shilov EM; Pal'tsev MA; Tareeva IE Arkh Patol; 1990; 52(4):53-7. PubMed ID: 2386442 [TBL] [Abstract][Full Text] [Related]
31. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model. Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994 [TBL] [Abstract][Full Text] [Related]
32. Involvement of bone marrow-derived endothelial progenitor cells in glomerular capillary repair in habu snake venom-induced glomerulonephritis. Abe-Yoshio Y; Abe K; Miyazaki M; Furusu A; Nishino T; Harada T; Koji T; Kohno S Virchows Arch; 2008 Jul; 453(1):97-106. PubMed ID: 18551312 [TBL] [Abstract][Full Text] [Related]
33. [Suppressive effects of GTW treatment on mesangial lesions in experimental irreversible glomerulosclerosis]. Wan YG; Sun W; Shmizu F; Gu LB; Suziki K; Karasawa T; Kawachi H Zhongguo Zhong Yao Za Zhi; 2005 Mar; 30(5):361-5. PubMed ID: 15806970 [TBL] [Abstract][Full Text] [Related]
34. Expression of tenascin in mesangial injury in experimental glomerulonephritis. Jyo Y; Sasaki T; Nomura S; Tamai H; Kawai S; Osawa G; Nakao N; Kusakabe M Exp Nephrol; 1997; 5(5):423-8. PubMed ID: 9386979 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic effect of sulphated hyaluronic acid, a potential selectin-blocking agent, on experimental progressive mesangial proliferative glomerulonephritis. Matsuda M; Shikata K; Shimizu F; Suzuki Y; Miyasaka M; Kawachi H; Kawashima H; Wada J; Sugimoto H; Shikata Y; Ogawa D; Tojo SJ; Akima K; Makino H J Pathol; 2002 Nov; 198(3):407-14. PubMed ID: 12375274 [TBL] [Abstract][Full Text] [Related]
36. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Tipping PG; Kitching AR; Huang XR; Mutch DA; Holdsworth SR Eur J Immunol; 1997 Feb; 27(2):530-7. PubMed ID: 9045927 [TBL] [Abstract][Full Text] [Related]
38. A correlation between immunoexpression of CD44, alpha-SMA and CD68+ cells in IgA-nephropathy and in mesangial proliferative IgA-negative glomerulonephritis. Wagrowska-Danilewicz M; Danilewicz M Pol J Pathol; 2002; 53(3):155-62. PubMed ID: 12476618 [TBL] [Abstract][Full Text] [Related]
39. The relation of IgM deposition to clinical parameters and histomorphometry in childhood mesangial proliferative glomerulonephritis. Kasap B; Türkmen M; Sarioğlu S; Sis B; Soylu A; Kavukçu S Pathol Res Pract; 2008; 204(3):149-53. PubMed ID: 18093746 [TBL] [Abstract][Full Text] [Related]
40. Adrenomedullin (AM) and receptor-activity-modifying proteins in glomeruli with Thy.1 glomerulonephritis. Matsumoto M; Fujimoto S; Iwatsubo S; Sato Y; Hara S; Kitamura K; Eto T Clin Exp Nephrol; 2004 Dec; 8(4):316-21. PubMed ID: 15619030 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]